Functionally, STAT3 is a key oncogenic transcription factor involved in promoting cell proliferation, survival, and immune evasion in hepatocellular carcinoma (HCC), while CASP3 plays a central role in executing apoptosis—a process often suppressed during cancer progression. Here, STAT3 is linked to hepatocellular carcinoma.